Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy.

Nehls M.

J Mol Psychiatry. 2016 Jul 15;4:3. doi: 10.1186/s40303-016-0018-8. eCollection 2016. Review.

2.

Tackling amyloidogenesis in Alzheimer's disease with A2V variants of Amyloid-β.

Di Fede G, Catania M, Maderna E, Morbin M, Moda F, Colombo L, Rossi A, Cagnotto A, Virgilio T, Palamara L, Ruggerone M, Giaccone G, Campagnani I, Costanza M, Pedotti R, Salvalaglio M, Salmona M, Tagliavini F.

Sci Rep. 2016 Feb 11;6:20949. doi: 10.1038/srep20949.

3.

Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.

Audrain M, Fol R, Dutar P, Potier B, Billard JM, Flament J, Alves S, Burlot MA, Dufayet-Chaffaud G, Bemelmans AP, Valette J, Hantraye P, Déglon N, Cartier N, Braudeau J.

Mol Neurodegener. 2016 Jan 12;11:5. doi: 10.1186/s13024-016-0070-y.

4.

SUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease?

Hoppe JB, Salbego CG, Cimarosti H.

Aging Dis. 2015 Oct 1;6(5):322-30. doi: 10.14336/AD.2014.1205. eCollection 2015 Sep. Review.

5.

Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.

Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A.

Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1119-32. doi: 10.1007/s00259-015-3047-0. Epub 2015 Apr 17.

6.

GSK3β inhibition promotes synaptogenesis in Drosophila and mammalian neurons.

Cuesto G, Jordán-Álvarez S, Enriquez-Barreto L, Ferrús A, Morales M, Acebes Á.

PLoS One. 2015 Mar 12;10(3):e0118475. doi: 10.1371/journal.pone.0118475. eCollection 2015.

7.

Neuroprotective effects of geniposide in SH-SY5Y cells and primary hippocampal neurons exposed to Aβ42.

Sun P, Ding H, Liang M, Li X, Mo W, Wang X, Liu Y, He R, Hua Q.

Biomed Res Int. 2014;2014:284314. doi: 10.1155/2014/284314. Epub 2014 Nov 18.

8.

Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease.

Morris GP, Clark IA, Vissel B.

Acta Neuropathol Commun. 2014 Sep 18;2:135. doi: 10.1186/s40478-014-0135-5. Review.

9.

RNA aptamer probes as optical imaging agents for the detection of amyloid plaques.

Farrar CT, William CM, Hudry E, Hashimoto T, Hyman BT.

PLoS One. 2014 Feb 26;9(2):e89901. doi: 10.1371/journal.pone.0089901. eCollection 2014.

10.

Analysis of the hippocampal proteome in ME7 prion disease reveals a predominant astrocytic signature and highlights the brain-restricted production of clusterin in chronic neurodegeneration.

Asuni AA, Gray B, Bailey J, Skipp P, Perry VH, O'Connor V.

J Biol Chem. 2014 Feb 14;289(7):4532-45. doi: 10.1074/jbc.M113.502690. Epub 2013 Dec 23.

11.

Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.

Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I, Fernandez-Carballo L, de Munain EL, Perez J, Marquie M, Serrano-Pozo A, Frosch MP, Lowe V, Parisi JE, Petersen RC, Ikonomovic MD, López OL, Klunk W, Hyman BT, Gómez-Isla T.

Brain. 2013 Aug;136(Pt 8):2510-26. doi: 10.1093/brain/awt171. Epub 2013 Jul 3.

12.

The proton-pump inhibitor lansoprazole enhances amyloid beta production.

Badiola N, Alcalde V, Pujol A, Münter LM, Multhaup G, Lleó A, Coma M, Soler-López M, Aloy P.

PLoS One. 2013;8(3):e58837. doi: 10.1371/journal.pone.0058837. Epub 2013 Mar 8.

13.

"Untangling" Alzheimer's disease and epilepsy.

Scharfman HE.

Epilepsy Curr. 2012 Sep;12(5):178-83. doi: 10.5698/1535-7511-12.5.178.

14.

Isolated amyloid-β(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia.

Paranjape GS, Gouwens LK, Osborn DC, Nichols MR.

ACS Chem Neurosci. 2012 Apr 18;3(4):302-11. doi: 10.1021/cn2001238. Epub 2012 Jan 9.

15.

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kövari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG.

J Neuropathol Exp Neurol. 2012 May;71(5):362-81. doi: 10.1097/NEN.0b013e31825018f7. Review.

16.

Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.

Mondragón-Rodríguez S, Perry G, Zhu X, Boehm J.

Int J Alzheimers Dis. 2012;2012:630182. doi: 10.1155/2012/630182. Epub 2012 Mar 8.

17.

Interaction between pathogenic proteins in neurodegenerative disorders.

Jellinger KA.

J Cell Mol Med. 2012 Jun;16(6):1166-83. doi: 10.1111/j.1582-4934.2011.01507.x. Review.

18.

Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.

DaRocha-Souto B, Coma M, Pérez-Nievas BG, Scotton TC, Siao M, Sánchez-Ferrer P, Hashimoto T, Fan Z, Hudry E, Barroeta I, Serenó L, Rodríguez M, Sánchez MB, Hyman BT, Gómez-Isla T.

Neurobiol Dis. 2012 Jan;45(1):425-37. doi: 10.1016/j.nbd.2011.09.002. Epub 2011 Sep 13.

19.

Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease.

Serrano-Pozo A, Mielke ML, Gómez-Isla T, Betensky RA, Growdon JH, Frosch MP, Hyman BT.

Am J Pathol. 2011 Sep;179(3):1373-84. doi: 10.1016/j.ajpath.2011.05.047. Epub 2011 Jul 21.

Items per page

Supplemental Content

Write to the Help Desk